C07D 211/92
Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings: with
Official title: with a hetero atom directly attached to the ring nitrogen atom
C07D211/92 (Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings: with) appears on 946 US grants and 1,049 published applications in this corpus.
Search patents in C07D- Granted patents
- 946
- Published applications
- 1,049
- Assignees
- 522
- Inventors
- 3,144
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 17 | 0 |
| 1977 | 8 | 0 |
| 1978 | 13 | 0 |
| 1979 | 3 | 0 |
| 1980 | 8 | 0 |
| 1981 | 6 | 0 |
| 1982 | 4 | 0 |
| 1983 | 4 | 0 |
| 1984 | 4 | 0 |
| 1985 | 4 | 0 |
| 1986 | 3 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 6 | 0 |
| 1990 | 7 | 0 |
| 1991 | 17 | 0 |
| 1992 | 6 | 0 |
| 1993 | 17 | 0 |
| 1994 | 15 | 0 |
| 1995 | 12 | 0 |
| 1996 | 7 | 0 |
| 1997 | 10 | 0 |
| 1998 | 8 | 0 |
| 1999 | 15 | 0 |
| 2000 | 17 | 0 |
| 2001 | 23 | 10 |
| 2002 | 33 | 28 |
| 2003 | 27 | 47 |
| 2004 | 18 | 49 |
| 2005 | 25 | 61 |
| 2006 | 26 | 50 |
| 2007 | 29 | 28 |
| 2008 | 19 | 35 |
| 2009 | 22 | 42 |
| 2010 | 28 | 58 |
| 2011 | 22 | 44 |
| 2012 | 32 | 31 |
| 2013 | 44 | 52 |
| 2014 | 34 | 51 |
| 2015 | 50 | 53 |
| 2016 | 39 | 59 |
| 2017 | 46 | 37 |
| 2018 | 44 | 51 |
| 2019 | 26 | 31 |
| 2020 | 33 | 39 |
| 2021 | 28 | 30 |
| 2022 | 17 | 40 |
| 2023 | 13 | 38 |
| 2024 | 20 | 32 |
| 2025 | 22 | 30 |
| 2026 | 9 | 23 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Substituted cyclohexyl compounds as NOP inhibitors2 Jun 2026US 12,643,888 B2Dart NeuroScience, LLC
- Opioid receptor agonist, preparation method therefor and pharmaceutical use thereof12 May 2026US 12,624,004 B2Fudan University
- Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency28 Apr 2026US 12,611,402 B2Centessa Pharmaceuticals (UK) Limited
- Process for the preparation of sterically hindered nitroxyl ethers14 Apr 2026US 12,600,818 B2GeneusChem AG
- Solution of tempo-derivatives for use as electrolyte in redox-flow cells17 Mar 2026US 12,577,203 B2BASF SE
- Cyclohexyl or heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia17 Sep 2026US 2026/0274785 A1Atrogi AB
- New e3 ubiquitin ligase ligand, protein degradation agent and use thereof17 Sep 2026US 2026/0274829 A1Gluetacs Therapeutics (Shanghai) Co., Ltd.
- Imine compounds as well as preparation method therefor and use thereof27 Aug 2026US 2026/0248763 A1Bio Genuine (Shanghai) Biotech Co., Ltd
- Heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia20 Aug 2026US 2026/0242335 A1Atrogi AB
- N,n'-sulfonimidamides as anticancer, antiinflammatory, antifibrotic and neuroprotective agents20 Aug 2026US 2026/0242349 A1Atux Iskay LLC
Most cited
By later US patents
- Arylsulfonyl hydroxamic acid derivatives as MMP and TNF inhibitors218US 5,861,510 APfizer Inc. · 1999
- Inhibitors of microsomal triglyceride transfer protein and method137US 5,712,279 ABristol-Myers Squibb Company · 1998
- Inhibitors of microsomal triglyceride transfer protein and method129US 5,739,135 ABristol-Myers Squibb Company · 1998
- Heterocyclo inhibitors of potassium channel function120US 7,005,436 B2Bristol-Myers Squibb Company · 2006
- O-substituted N-hydroxy hindered amine stabilizers95US 5,204,473 ACiba-Geigy Corporation · 1993